BIMI International Medical Inc.
BIMI International Medical Inc.（BIMI）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · BIMI · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
2
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
BIMI International Medical Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
BIMI 季度内部人买卖趋势
BIMI 内幕交易卖出 · BIMI 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
近期内幕交易记录
BIMI 高管卖出股份 · BIMI 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 12, 2024 | Oudom Fnu Director | Award | 1,123,500 | $1K | Form 4 |
| Feb 26, 2024 | Tiewei Song CEO · Director | Sale | 724 | $3K | Form 4 |
| Feb 28, 2024 | Tiewei Song CEO · Director | Sale | 4,000 | $16K | Form 4 |
| Jul 18, 2022 | Tiewei Song CEO | Award | 100,000 | $4.98B⚡ | Form 4 |
| Jul 18, 2022 | Tiewei Song CEO | Award | 124,427 | $7.32B⚡ | Form 4 |
| Jul 19, 2022 | Oudom Fnu Chaiman | Award | 12,500,000 | $5.00M⚡ | Form 4 |
| Apr 9, 2018 | GANG LI CEO · Director | Sale | 800,000 | $1.12M⚡ | Form 4 |
| Apr 9, 2018 | LIHUA WANG CFO · Director | Sale | 200,000 | $288K | Form 4 |
| May 7, 2015 | LIHUA WANG CFO · Director | Other | 166,828 | $344K | Form 4 |
| May 7, 2015 | GANG LI CEO · Director | Other | 667,314 | $1.37M⚡ | Form 4 |
| Aug 28, 2014 | Psomiadis Themistocles Director | Sale | 19,925 | $20K | Form 4 |
| Aug 26, 2014 | Psomiadis Themistocles Director | Sale | 19,925 | $21K | Form 4 |
| Aug 21, 2014 | Psomiadis Themistocles Director | Sale | 13,500 | $17K | Form 4 |
| Aug 25, 2014 | Psomiadis Themistocles Director | Sale | 3,425 | $4K | Form 4 |
| Jul 23, 2014 | Psomiadis Themistocles Director | Sale | 400 | $472 | Form 4 |
| Jul 22, 2014 | Psomiadis Themistocles Director | Sale | 1,250 | $2K | Form 4 |
| Jul 21, 2014 | Psomiadis Themistocles Director | Sale | 1,000 | $1K | Form 4 |
| Mar 11, 2013 | LEIGHTON DOUGLAS Director | Other | 19,000,000 | — | Form 4 |
| Mar 11, 2013 | LEIGHTON DOUGLAS Director | Other | 19,000,000 | — | Form 4 |
| Mar 11, 2013 | LEIGHTON DOUGLAS Director | Other | 800,000 | $448K | Form 4 |
| Jul 25, 2013 | LEIGHTON DOUGLAS Director | Other | 1,950,260 | — | Form 4 |
| May 14, 2013 | NOVIELLI MICHAEL A Director | Other | 1,875,000 | — | Form 4 |
| Mar 11, 2013 | NOVIELLI MICHAEL A Director | Other | 4,152,295 | — | Form 4 |
| Mar 11, 2013 | NOVIELLI MICHAEL A Director | Other | 19,000,000 | — | Form 4 |
| Oct 1, 2013 | NOVIELLI MICHAEL A Director | Other | 800,000 | $448K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 BIMI 内幕交易
BIMI 内幕交易
BIMI International Medical Inc.（BIMI）内幕交易数据来源于公司内部人（包括BIMI）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。BIMI内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看BIMI International Medical Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
BIMI 内幕交易 · 5个问题BIMI International Medical Inc.（BIMI）的内部人包括高管和董事，如BIMI等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026